ATF2 Antikörper (AA 188-255)
Kurzübersicht für ATF2 Antikörper (AA 188-255) (ABIN669546)
Target
Alle ATF2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
- 
    
- 
                                            
Bindungsspezifität
 - AA 188-255
 - 
                                            
Kreuzreaktivität
 - Human, Maus, Ratte
 - 
                                            
Aufreinigung
 - Purified by Protein A.
 - 
                                            
Immunogen
 - KLH conjugated synthetic peptide derived from human ATF2
 - 
                                            
Isotyp
 - IgG
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
Applikationshinweise
 - 
                        WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - 
                                            
Beschränkungen
 - Nur für Forschungszwecke einsetzbar
 
 - 
                                            
 - 
    
- 
                                            
Format
 - Liquid
 - 
                                            
Konzentration
 - 1 μg/μL
 - 
                                            
Buffer
 - 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
 - 
                                            
Konservierungsmittel
 - ProClin
 - 
                                            
Vorsichtsmaßnahmen
 - This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
 - 
                                            
Lagerung
 - 4 °C,-20 °C
 - 
                                            
Informationen zur Lagerung
 - Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
 - 
                                            
Haltbarkeit
 - 12 months
 
 - 
                                            
 - 
    
- 
                                            : "Interleukin 18 augments growth ability via NF-?B and p38/ATF2 pathways by targeting cyclin B1, cyclin B2, cyclin A2, and Bcl-2 in BRL-3A rat liver cells."    in: Gene, Vol. 563, Issue 1, pp. 45-51, (2015)         (PubMed).        
 
 - 
                                            : "Interleukin 18 augments growth ability via NF-?B and p38/ATF2 pathways by targeting cyclin B1, cyclin B2, cyclin A2, and Bcl-2 in BRL-3A rat liver cells."    in: Gene, Vol. 563, Issue 1, pp. 45-51, (2015)         (PubMed).        
 - 
    
- ATF2 (Activating Transcription Factor 2 (ATF2))
 - 
                                            
Andere Bezeichnung
 - ATF2
 - 
                                            
Hintergrund
 - 
                        
Synonyms: HB16, CREB2, TREB7, CREB-2, CRE-BP1, Cyclic AMP-dependent transcription factor ATF-2, cAMP-dependent transcription factor ATF-2, Activating transcription factor 2, Cyclic AMP-responsive element-binding protein 2, cAMP-responsive element-binding protein 2, Histone acetyltransferase ATF2, cAMP response element-binding protein CRE-BP1, ATF2, CREBP1
Background: Transcriptional activator which regulates the transcription of various genes, including those involved in anti-apoptosis, cell growth, and DNA damage response. Dependent on its binding partner, binds to CRE (cAMP response element) consensus sequences (5'-TGACGTCA-3') or to AP-1 (activator protein 1) consensus sequences (5'-TGACTCA-3'). In the nucleus, contributes to global transcription and the DNA damage response, in addition to specific transcriptional activities that are related to cell development, proliferation and death. In the cytoplasm, interacts with and perturbs HK1- and VDAC1-containing complexes at the mitochondrial outer membrane, thereby impairing mitochondrial membrane potential, inducing mitochondrial leakage and promoting cell death. The phosphorylated form (mediated by ATM) plays a role in the DNA damage response and is involved in the ionizing radiation (IR)-induced S phase checkpoint control and in the recruitment of the MRN complex into the IR-induced foci (IRIF). Exhibits histone acetyltransferase (HAT) activity which specifically acetylates histones H2B and H4 in vitro. In concert with CUL3 and RBX1, promotes the degradation of KAT5 thereby attenuating its ability to acetylate and activate ATM. Can elicit oncogenic or tumor suppressor activities depending on the tissue or cell type.
 - 
                                            
Gen-ID
 - 1386
 - 
                                            
UniProt
 - P15336
 - 
                                            
Pathways
 - MAPK Signalweg, RTK Signalweg, Thyroid Hormone Synthesis, Activation of Innate immune Response, Chromatin Binding, Myometrial Relaxation and Contraction, Synaptic Membrane, Tube Formation, Toll-Like Receptors Cascades
 
Target
 -